Get all your news in one place.

100’s of premium titles.
One app.

Get all your news in one place.

100’s of premium titles. One news app.

The Latest Breaking News from Pacific Biosciences

Why Cathie Wood Thinks Stock Fears Are At 'Depression' Levels

Why does Cathie Wood think investors' fear about stocks is at "Great Depression" levels? Because it is for her portfolio.

Investors Business Daily

Illumina’s Sudden CEO Exit Is Just One of Many Problems Facing DNA Company

The sudden resignation of Francis deSouza raises questions about the firm’s future after its proxy fight with Carl Icahn.

Cathie Wood Is Crushing It This Year Thanks To 9 Stocks

Cathie Wood Is Crushing It This Year Thanks To 9 Stocks

Cathie Wood's ARK Innovation ETF is back — and back big. It's the top diversified ETF again this year so far, largely due to big winners.

Investors Business Daily

From analysis to the latest developments in health,
read the most diverse news in one place.

inkl

12 Health Care Stocks Moving In Friday's Intraday Session

Piper Sandler Maintains Neutral Rating for Pacific Biosciences: Here's What You Need To Know

Piper Sandler has decided to maintain its Neutral rating of Pacific Biosciences (NASDAQ:PACB) and lower its price target from $13.00 to $6.00. Shares of Pacific Biosciences are trading down 2.74% over the last 24 hours, at $5.68 per share.

Recap: Pacific Biosciences Q1 Earnings

Pacific Biosciences (NASDAQ:PACB) reported its Q1 earnings results on Wednesday, May 4, 2022 at 04:00 PM. Here's what investors need to know about the announcement.

From wolf to chihuahua: new research reveals where the dingo sits on the evolutionary timeline of dogs

Many people know modern dogs evolved from the grey wolf. But did you know most of the more than 340 modern dog breeds we have today only emerged within the past 200 years?

The Conversation

inkl

Read news from The Economist, FT, and more,
with one subscription

Recap: Pacific Biosciences Q4 Earnings

Recap: Pacific Biosciences Q4 Earnings

Pacific Biosciences (NASDAQ:PACB) reported its Q4 earnings results on Tuesday, February 15, 2022 at 04:00 PM. Here's what investors need to know about the announcement.

People

From analysis to the latest developments in health,
read the most diverse news in one place.

inkl

Organisations

SP Global Market Intelligence

Communication Services

Morningstar Direct

inkl

Read news from The Economist, FT, and more,
with one subscription

Topics

Great Depression

Places

254,327 stories

Fourteen days free

Download the app

One app. One membership.
100+ trusted global sources.

Download on the AppStore

Get it on Google Play